Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Cadila Healthcare Limited patents


Recent patent applications related to Cadila Healthcare Limited. Cadila Healthcare Limited is listed as an Agent/Assignee. Note: Cadila Healthcare Limited may have other listings under different names/spellings. We're not affiliated with Cadila Healthcare Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cadila Healthcare Limited-related inventors


Saroglitazar magnesium for the treatment of chylomicronemia syndrome

The present invention relates to the use of saroglitazar magnesium of formula (1), for the prevention, delay of progression, or treatment of a disease or condition which is selected from chylomicronemia syndrome, familial chylomicronemia syndrome and type v hyperlipoproteinemia. The present invention further relates to the use of a pharmaceutical composition comprising saroglitazar magnesium for the prevention, delay of progression, or treatment of a disease or condition which is selected from chylomicronemia syndrome, familial chylomicronemia syndrome and type v hyperlipoproteinemia.. ... Cadila Healthcare Limited

Novel crystalline form of rifaximin and process for its preparation

A novel crystalline form of rifaximin and process for its preparation are described. A pharmaceutical composition comprising crystalline rifaximin is also described.. ... Cadila Healthcare Limited

Process for the preparation of brexpiprazole and intermediates thereof

The present invention relates to brexpiprazole having a purity of about 99.5% or more by area percentage of hplc, having total impurities not more than 0.5% relative to brexpiprazole as measured by area percentage of hplc, and having less than 0.1% 1-(benzo[b]thiophen-4-yl)piperazine or a salt thereof relative to brexpiprazole by area percentage of hplc. The present invention also provides a composition comprising brexpiprazole having 1-(benzo[b]thiophen-4-yl)-piperazine or a salt thereof in an amount less than about 0.1% relative to brexpiprazole by area percentage of hplc and process for the preparation of brexpiprazole.. ... Cadila Healthcare Limited

Synergistic compositions

The present invention describes a synergistic composition comprising of one or more statins, or one or more dipeptidyl peptidase iv (dpp iv) inhibitor or one or more biguanide antihyperglycaemic agent and a ppar agonist of formula (1a) for the treatment of diabetes, especially non-insulin dependent diabetes or type 2 diabetes and conditions associated with diabetes mellitus and to compositions suitable for use in such method. The invention also describes the preparation of such compositions. ... Cadila Healthcare Limited

Amorphous form of daclatasvir and its salts and process for preparation thereof

This relates to an amorphous form of daclatasvir and its salts and process for preparation thereof. In particular, it relates to an amorphous form of daclatasvir and daclatasvir dihydrochloride. ... Cadila Healthcare Limited

Formula comprising a hypolipidemic agent

The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (i), or pharmaceutically acceptable salts of compounds of formula (i). ... Cadila Healthcare Limited

Processes for the preparation of empagliflozin

The present invention relates to processes for the preparation of empagliflozin. In particular, the present invention relates to the preparation of empagliflozin and intermediates thereof. ... Cadila Healthcare Limited

Polymorphic forms of ivabradine hydrochloride

Stable crystalline form ii and stable crystalline form iii of ivabradine hydrochloride and processes for their preparation are disclosed.. . ... Cadila Healthcare Limited

Process for the preparation of dapagliflozin

Dapagliflozin compounds and process for dapagliflozin preparation are described. Pharmaceutical compositions comprising dapagliflozin or solvates of dapagliflozin, for the treatment of diabetes are also described.. ... Cadila Healthcare Limited

Process for preparation of androgen receptor antagonist

The present invention provides an isopropanol solvate of enzalutamide. The present invention also provides a process for the preparation of androgen receptor antagonist. ... Cadila Healthcare Limited

Olaparib co-precipitate and preparation method thereof

The present invention relates to co-precipitates of olaparib and an ionic polymer and pharmaceutical composition containing the co-precipitates. Further, the present invention relates to a method of treating disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said composition.. ... Cadila Healthcare Limited

Treatment for lipodystrophy

The present invention provides a therapeutic compound of formula (i) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of hiv infection or combination therapy of hiv-1 protease inhibitors (pis) and/or reverse transcriptase inhibitors (nrtis) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in hiv patient.. . ... Cadila Healthcare Limited

Novel composition for nonalcoholic fatty liver disease (nafld)

The present invention provides a compound of formula (i) or pharmaceutical acceptable thereof, wherein ‘r’ is herein described. In addition, the invention relates to composition comprising effective therapeutic amount of compound of formula (i) and methods of using the compounds for treating or prevention disorder such as nonalcoholic fatty liver disease (nafld) including fatty liver (steatosis), nonalcoholic steatohepatitis (nash), and cirrhosis (advanced scarring of the liver).. ... Cadila Healthcare Limited

Novel purification process of gonadotropin

The present invention provides an improved method for the purification of desired gonadotropin from a crude mixture containing at least one contaminating protein. The process of purification of the desired gonadotropin according to the present invention comprises use of an affinity chromatography as the first column purification step, prior to use of any column chromatography steps for further purification. ... Cadila Healthcare Limited

01/12/17 / #20170007610

Novel heterobicyclic compounds as kappa opioid agonists

The present invention relates to novel compounds of the general formula (i), which are selective and peripherally acting kor agonist, their tautomeric forms, their enantiomers, their diastereoisomers, their stereoisomers, their pharmaceutically accepted salts, or prodrugs thereof which are useful in the treatment or prevention of diseases in which the kappa (κ) opioid receptors (kor) are involved, such as treatment or prevention of visceral pain, hyperalgesia, rheumatoid arthritic inflammation, osteoarthritic inflammation, ibd inflammation, ibs inflammation, ocular inflammation, otitic inflammation or autoimmune inflammation. The invention also relates to process for the manufacture of said compounds, and pharmaceutical compositions containing them and their use.. ... Cadila Healthcare Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cadila Healthcare Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cadila Healthcare Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###